Patent 8957109 was granted and assigned to MEI Pharma on February, 2015 by the United States Patent and Trademark Office.
Chroman derivatives and intermediate compounds, compositions containing same, methods for their preparation and uses thereof as therapeutic agents particularly as anti-cancer and chemotherapeutic selective agents are described.